No Data
No Data
Bloom Burton Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $9
Analysts Have Conflicting Sentiments on These Healthcare Companies: Castle Biosciences (CSTL), AbCellera Biologics (ABCL) and Apellis Pharmaceuticals (APLS)
Benchmark Co. Maintains AbCellera Biologics(ABCL.US) With Hold Rating
AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
AbCellera Biologics' Earnings Call: Transition Amid Challenges
AbCellera Biologics Analyst Ratings
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...